1426684-99-2Relevant articles and documents
Novel 1-(4-substituted benzylidene)-4-(1-(substituted methyl)-2,3- dioxoindolin-5-yl)semicarbazide derivatives for use against Mycobacterium tuberculosis H37Rv (ATCC 27294) and MDR-TB strain
Raja, Sundararajan,Prakash, Chinnasamy Rajaram
, p. 411 - 422 (2013/07/19)
A series of eighteen new 1-(4-substituted benzylidene)-4-(1-(substituted methyl)-2,3-dioxoindolin-5-yl)semicarbazide derivatives were designed, synthesized and characterized by spectral and elemental analyses. The derivatives were screened in vitro for an